Logo
i

ikarovec

6 employees

Ikarovek is working on early stage assets intended for the treatment of diabetic macular edama.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
ocular hypertension
Life Science
wet age-related macular degeneration
gene therapy
ophthalmology
Health Care
geographic atrophy
diabetic macular edema (DME)

Date founded

2018

Funding rounds raised

Total raised

$3.3M

from 2 investors over 2 rounds

i

ikarovec raised $3.3M on February 5, 2020

Investors: UK Innovation & Science Seed Fund and Parkwalk Advisors

FAQ